1. Daring discourse – no: cannabinoids should not be used for acute postoperative pain management
- Author
-
Jennifer D Meeker, Eugenia Ayrian, and Edward R. Mariano
- Subjects
Analgesics ,Pain, Postoperative ,medicine.medical_specialty ,Do no harm ,Cannabinoids ,business.industry ,Chronic pain ,Treatment options ,General Medicine ,Perioperative ,medicine.disease ,Acute Pain ,03 medical and health sciences ,0302 clinical medicine ,Anesthesiology and Pain Medicine ,030202 anesthesiology ,medicine ,Humans ,Pain Management ,Acute postoperative pain ,030212 general & internal medicine ,Intensive care medicine ,business ,Acute pain - Abstract
As anesthesiologists and acute pain medicine specialists, we will care for patients in the perioperative period who use cannabinoids for chronic pain and/or marijuana recreationally. We will have to address difficult questions from patients regarding the potential applications for cannabinoids in acute pain management. While we must remain compassionate and understand our patients’ desire to find relief from suffering using available non-opioid medications, we are ethically bound to do no harm and provide them with treatment options supported by the best available evidence. Today, we cannot support cannabinoids in the management of acute postoperative pain.
- Published
- 2020
- Full Text
- View/download PDF